ArticleBMC pregnancy and childbirth2025
Development and external validation of a non-invasive early gestational diabetes mellitus prediction model integrating social network variables: a machine learning-based prospective cohort study.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveCurrent predictive models for gestational diabetes mellitus (GDM) largely overlook the role of social network factors. This study aimed to develop and validate an early GDM prediction model by integrating social network characteristics with traditional non-invasive predictors using machine learning (ML).
methodsThis prospective cohort study enrolled 2,433 pregnant individuals from four branches of Qingdao University Affiliated Hospital as the model development cohort and external validation cohort. After screening variables via univariate analysis, significant predictors were used to train seven ML algorithms: Logistic Regression (LR), Random Forest (RF), eXtreme Gradient Boosting (XGBoost), K-Nearest Neighbors (KNN), Support Vector Classifier (SVC), Adaptive Boosting (AdaBoost) and Multilayer Perceptron (MLP). A 30-times repeated stratified 10-fold cross-validation procedure was employed, ensuring the preservation of the class distribution in every fold. Performance was assessed using the area under the receiver operating characteristic curve (AUC-ROC), accuracy, recall, specificity and F1 score. External validation evaluated the model's predictive performance and clinical effectiveness via ROC curves, Calibration curves, and decision curve analysis (DCA).
resultsOne thousand seven hundred fifty-two cases were included in the model development cohort and 681 cases were included in the geographically independent external validation cohort. Twenty-two risk factors for GDM were screened out through univariate logistic regression, covering sociodemographic characteristics, social network characteristics (such as the scale of the structural network and the semi-annual total contact frequency), and personal behavioral characteristics. The XGBoost model demonstrated the optimal comprehensive performance (AUC = 0.980), significantly outperforming other algorithms. External validation further confirmed that the model has excellent generalization ability (AUC = 0.901), though with room to improve upon its sensitivity. The Calibration curve showed that the predicted results were in good agreement with actual observations, and DCA exhibited a superior net benefit across a wide range of threshold probabilities.
conclusionsThis study developed a high-performance GDM prediction model by integrating social network variables with conventional predictors. The XGBoost-based algorithm showed robust performance in external validation, demonstrating that social network metrics significantly enhance risk stratification beyond traditional clinical factors. It reveals the potential value of social network factors in predicting GDM, providing new ideas and methods for constructing GDM prediction models with higher predictive ability and more stable performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.